Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

To assess the beneficial and harmful effects of drugs improving insulin resistance for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

This is a protocol.

You may also be interested in:

Statins for non-alcoholic steatohepatitis
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
No evidence to support or refute antioxidant supplements for patients with non-alcoholic fatty liver disease and/or steatohepatitis
No evidence to support or refute probiotics for patients with non-alcoholic fatty liver disease and/or steatohepatitis
Medical treatment for people with non-alcohol related fatty liver disease

Health topics:

Gastroenterology & hepatology > Liver disorders > Fatty liver

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.